Peripheral 5-HT7 receptors as a new target for prevention of lung injury and mortality in septic rats

Immunobiology

Volumn 218, Issue 10, 2013, Pages 1271-1283

  Cadirci, Elif ^a   Halici, Zekai ^b   Bayir, Yasin ^a   Albayrak, Abdulmecit ^b   Karakus, Emre ^a   Polat, Beyzagul ^a   Unal, Deniz ^b   Atamanalp, Sabri S ^b   Aksak, Selina ^b   Gundogdu, Cemal ^b  

^a ATATÜRK UNIVERSITY   (Turkey)

^b ATATURK UNIVERSITY   (Turkey)

Author keywords

5 HT7 receptor; CLP; NF B; Rat; Sepsis

Indexed keywords

8 ISOPROSTANE; AS 19; GLUTATHIONE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; SEROTONIN 7 RECEPTOR; SEROTONIN AGONIST; SUPEROXIDE DISMUTASE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ACUTE LUNG INJURY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; CYTOKINE RESPONSE; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; MALE; MORTALITY; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; RECEPTOR DENSITY; SEPSIS; SURVIVAL TIME;

5-HT7 RECEPTOR; CLP; NF-ΚB; RAT; SEPSIS;

ANIMALS; CECUM; CYTOKINES; LUNG; MALE; MOLECULAR TARGETED THERAPY; OXIDATIVE STRESS; PHENOLS; PROTEIN-SERINE-THREONINE KINASES; RATS; RATS, WISTAR; RECEPTORS, SEROTONIN; SEPSIS; SEROTONIN ANTAGONISTS; SEROTONIN RECEPTOR AGONISTS; SULFONAMIDES;

EID: 84881026178     PISSN: 01712985     EISSN: 18783279     Source Type: Journal    
DOI: 10.1016/j.imbio.2013.04.012     Document Type: Article

References (60)

1. Albayrak A., Uyanik M.H., Odabasoglu F., Halici Z., Uyanik A., Bayir Y., Albayrak F., Albayrak Y., Polat B., Suleyman H. The effects of diabetes and/or polymicrobial sepsis on the status of antioxidant enzymes and pro-inflammatory cytokines on heart, liver, and lung of ovariectomized rats. J. Surg. Res. 2011, 169:67.
2. Alberti C., Brun-Buisson C., Burchardi H., Martin C., Goodman S., Artigas A., Sicignano A., Palazzo M., Moreno R., Boulme R., Lepage E., Le Gall R. Epidemiology of sepsis and infection in ICU patients from an international multicentre cohort study. Intensive Care Med. 2002, 28:108.
3. Bhatia M., Moochhala S. Role of inflammatory mediators in the pathophysiology of acute respiratory distress syndrome. J. Pathol. 2004, 202:145.
4. Bone R.C. The pathogenesis of sepsis. Ann. Intern. Med. 1991, 115:457.
5. Bosker F.J., Folgering J.H., Gladkevich A.V., Schmidt A., van der Hart M.C., Sprouse J., den Boer J.A., Westerink B.H., Cremers T.I. Antagonism of 5-HT(1A) receptors uncovers an excitatory effect of SSRIs on 5-HT neuronal activity, an action probably mediated by 5-HT(7) receptors. J. Neurochem. 2009, 108:1126.
6. Cadirci E., Altunkaynak B.Z., Halici Z., Odabasoglu F., Uyanik M.H., Gundogdu C., Suleyman H., Halici M., Albayrak M., Unal B. Alpha-lipoic acid as a potential target for the treatment of lung injury caused by cecal ligation and puncture-induced sepsis model in rats. Shock 2010, 33:479.
7. Cadirci E., Oral A., Odabasoglu F., Kilic C., Coskun K., Halici Z., Suleyman H., Nuri Keles O., Unal B. Atorvastatin reduces tissue damage in rat ovaries subjected to torsion and detorsion: biochemical and histopathologic evaluation. Naunyn Schmiedebergs Arch. Pharmacol. 2010, 381:455.
8. Cadirci E., Halici Z., Odabasoglu F., Albayrak A., Karakus E., Unal D., Atalay F., Ferah I., Unal B. Sildenafil treatment attenuates lung and kidney injury due to overproduction of oxidant activity in a rat model of sepsis: a biochemical and histopathological study. Clin. Exp. Immunol. 2011, 166:374.
9. Cazzola I., Matera M.G. 5-HT modifiers as a potential treatment of asthma. Trends Pharmacol. Sci. 2000, 21:13.
10. Chen J., Raj N., Kim P., Andrejko K.M., Deutschman C.S. Intrahepatic nuclear factor-kappa B activity and alpha 1-acid glycoprotein transcription do not predict outcome after cecal ligation and puncture in the rat. Crit. Care Med. 2001, 29:589.
11. Coskun A.K., Yigiter M., Oral A., Odabasoglu F., Halici Z., Mentes O., Cadirci E., Atalay F., Suleyman H. The effects of montelukast on antioxidant enzymes and proinflammatory cytokines on the heart, liver, lungs, and kidneys in a rat model of cecal ligation and puncture-induced sepsis. Sci. World J. 2011, 11:1341.
12. Damas P., Ledoux D., Nys M., Vrindts Y., De Groote D., Franchimont P., Lamy M. Cytokine serum level during severe sepsis in human IL-6 as a marker of severity. Ann. Surg. 1992, 215:356.
13. Durk T., Panther E., Muller T., Sorichter S., Ferrari D., Pizzirani C., Di Virgilio F., Myrtek D., Norgauer J., Idzko M. 5-Hydroxytryptamine modulates cytokine and chemokine production in LPS-primed human monocytes via stimulation of different 5-HTR subtypes. Int. Immunol. 2005, 17:599.
14. Fink M.P. Reactive oxygen species as mediators of organ dysfunction caused by sepsis, acute respiratory distress syndrome, or hemorrhagic shock: potential benefits of resuscitation with Ringer's ethyl pyruvate solution. Curr. Opin. Clin. Nutr. Metab. Care 2002, 5:167.
15. Forbes I.T., Douglas S., Gribble A.D., Ife R.J., Lightfoot A.P., Garner A.E., Riley G.J., Jeffrey P., Stevens A.J., Stean T.O., Thomas D.R. SB-656104-A: a novel 5-HT(7) receptor antagonist with improved in vivo properties. Bioorg. Med. Chem. Lett. 2002, 12:3341.
16. Garcia J.J., Reiter R.J., Guerrero J.M., Escames G., Yu B.P., Oh C.S., Munoz-Hoyos A. Melatonin prevents changes in microsomal membrane fluidity during induced lipid peroxidation. FEBS Lett. 1997, 408:297.
17. Hedlund P.B. The 5-HT7 receptor and disorders of the nervous system: an overview. Psychopharmacology (Berl.) 2009, 206:345.
18. Hedlund P.B., Sutcliffe J.G. Functional, molecular and pharmacological advances in 5-HT7 receptor research. Trends Pharmacol. Sci. 2004, 25:481.
19. Hedlund P.B., Kelly L., Mazur C., Lovenberg T., Sutcliffe J.G., Bonaventure P. 8-OH-DPAT acts on both 5-HT1A and 5-HT7 receptors to induce hypothermia in rodents. Eur. J. Pharmacol. 2004, 487:125.
20. Heidmann D.E., Metcalf M.A., Kohen R., Hamblin M.W. Four 5-hydroxytryptamine7 (5-HT7) receptor isoforms in human and rat produced by alternative splicing: species differences due to altered intron-exon organization. J. Neurochem. 1997, 68:1372.
21. Hotchkiss R.S., Karl I.E. The pathophysiology and treatment of sepsis. N. Engl. J. Med. 2003, 348:138.
22. Hubbard W.J., Choudhry M., Schwacha M.G., Kerby J.D., Rue L.W., Bland K.I., Chaudry I.H. Cecal ligation and puncture. Shock 2005, 24(Suppl. 1):52.
23. Iskit A.B. Sepsiste deneysel modeller. Yoǧun Bakim Derg. 2005, 5:133.
24. Kuwano K., Hara N. Signal transduction pathways of apoptosis and inflammation induced by the tumor necrosis factor receptor family. Am. J. Respir. Cell Mol. Biol. 2000, 22:147.
25. Leon-Ponte M., Ahern G.P., O'Connell P.J. Serotonin provides an accessory signal to enhance T-cell activation by signaling through the 5-HT7 receptor. Blood 2007, 109:3139.
26. Li Q.F., Zhu Y.S., Jiang H., Xu H., Sun Y. Heme oxygenase-1 mediates the anti-inflammatory effect of isoflurane preconditioning in LPS-stimulated macrophages. Acta Pharmacol. Sin. 2009, 30:228.
27. MaassenVanDenBrink A., Centurion D., Villalon C.M. Crosstalk of vascular 5-HT1 receptors with other receptors: clinical implications. Neuropharmacology 2008, 55:986.
28. Matsuda H., Ushio H., Geba G.P., Askenase P.W. Human platelets can initiate T cell-dependent contact sensitivity through local serotonin release mediated by IgE antibodies. J. Immunol. 1997, 158:2891.
29. Metnitz P.G., Bartens C., Fischer M., Fridrich P., Steltzer H., Druml W. Antioxidant status in patients with acute respiratory distress syndrome. Intensive Care Med. 1999, 25:180.
30. Moine P., Abraham E. Immunomodulation and sepsis: impact of the pathogen. Shock 2004, 22:297.
31. Neumaier J.F., Sexton T.J., Yracheta J., Diaz A.M., Brownfield M. Localization of 5-HT(7) receptors in rat brain by immunocytochemistry, in situ hybridization, and agonist stimulated cFos expression. J. Chem. Neuroanat. 2001, 21:63.
32. Nilsson T., Longmore J., Shaw D., Pantev E., Bard J.A., Branchek T., Edvinsson L. Characterisation of 5-HT receptors in human coronary arteries by molecular and pharmacological techniques. Eur. J. Pharmacol. 1999, 372:49.
33. Ortolani O., Conti A., De Gaudio A.R., Moraldi E., Cantini Q., Novelli G. The effect of glutathione and N-acetylcysteine on lipoperoxidative damage in patients with early septic shock. Am. J. Respir. Crit. Care Med. 2000, 161:1907.
34. Otero-Anton E., Gonzalez-Quintela A., Lopez-Soto A., Lopez-Ben S., Llovo J., Perez L.F. Cecal ligation and puncture as a model of sepsis in the rat: influence of the puncture size on mortality, bacteremia, endotoxemia and tumor necrosis factor alpha levels. Eur. Surg. Res. 2001, 33:77.
35. Ozdulger A., Cinel I., Koksel O., Cinel L., Avlan D., Unlu A., Okcu H., Dikmengil M., Oral U. The protective effect of N-acetylcysteine on apoptotic lung injury in cecal ligation and puncture-induced sepsis model. Shock 2003, 19:366.
36. Qiao Y., Bai X.F., Du Y.G. Chitosan oligosaccharides protect mice from LPS challenge by attenuation of inflammation and oxidative stress. Int. Immunopharmacol. 2011, 11:121.
37. Razavi H.M., Wang L., Weicker S., Quinlan G.J., Mumby S., McCormack D.G., Mehta S. Pulmonary oxidant stress in murine sepsis is due to inflammatory cell nitric oxide. Crit. Care Med. 2005, 33:1333.
38. Remick D.G., Bolgos G., Copeland S., Siddiqui J. Role of interleukin-6 in mortality from and physiologic response to sepsis. Infect. Immun. 2005, 73:2751.
39. Rhoden K.J., Dodson A.M., Ky B. Stimulation of the Na(+)-K(+) pump in cultured guinea pig airway smooth muscle cells by serotonin. J. Pharmacol. Exp. Ther. 2000, 293:107.
40. Sakurai H., Chiba H., Miyoshi H., Sugita T., Toriumi W. IkappaB kinases phosphorylate NF-kappaB p65 subunit on serine 536 in the transactivation domain. J. Biol. Chem. 1999, 274:30353.
41. Segura P., Vargas M.H., Cordoba-Rodriguez G., Chavez J., Arreola J.L., Campos-Bedolla P., Ruiz V., Garcia-Hernandez L.M., Mendez C., Montano L.M. Role of 5-HT2A, 5-HT4 and 5-HT7 receptors in the antigen-induced airway hyperresponsiveness in guinea-pigs. Clin. Exp. Allergy 2010, 40:327.
42. Shen Y., Monsma F.J., Metcalf M.A., Jose P.A., Hamblin M.W., Sibley D.R. Molecular cloning and expression of a 5-hydroxytryptamine7 serotonin receptor subtype. J. Biol. Chem. 1993, 268:18200.
43. Shen L., Mo H., Cai L., Kong T., Zheng W., Ye J., Qi J., Xiao Z. Losartan prevents sepsis-induced acute lung injury and decreases activation of nuclear factor kappaB and mitogen-activated protein kinases. Shock 2009, 31:500.
44. Singh B., Shinagawa K., Taube C., Gelfand E.W., Pabst R. Strain-specific differences in perivascular inflammation in lungs in two murine models of allergic airway inflammation. Clin. Exp. Immunol. 2005, 141:223.
45. Soga F., Katoh N., Inoue T., Kishimoto S. Serotonin activates human monocytes and prevents apoptosis. J. Invest. Dermatol. 2007, 127:1947.
46. Starr M.E., Ueda J., Yamamoto S., Evers B.M., Saito H. The effects of aging on pulmonary oxidative damage, protein nitration, and extracellular superoxide dismutase down-regulation during systemic inflammation. Free Radic. Biol. Med. 2011, 50:371.
47. Stefulj J., Jernej B., Cicin-Sain L., Rinner I., Schauenstein K. mRNA expression of serotonin receptors in cells of the immune tissues of the rat. Brain Behav. Immun. 2000, 14:219.
48. Tergaonkar V. NFkappaB pathway: a good signaling paradigm and therapeutic target. Int. J. Biochem. Cell Biol. 2006, 38:1647.
49. Thomas D.R., Melotto S., Massagrande M., Gribble A.D., Jeffrey P., Stevens A.J., Deeks N.J., Eddershaw P.J., Fenwick S.H., Riley G., Stean T., Scott C.M., Hill M.J., Middlemiss D.N., Hagan J.J., Price G.W., Forbes I.T. SB-656104-A, a novel selective 5-HT7 receptor antagonist, modulates REM sleep in rats. Br. J. Pharmacol. 2003, 139:705.
50. To Z.P., Bonhaus D.W., Eglen R.M., Jakeman L.B. Characterization and distribution of putative 5-ht7 receptors in guinea-pig brain. Br. J. Pharmacol. 1995, 115:107.
51. Tsou A.P., Kosaka A., Bach C., Zuppan P., Yee C., Tom L., Alvarez R., Ramsey S., Bonhaus D.W., Stefanich E., et al. Cloning and expression of a 5-hydroxytryptamine7 receptor positively coupled to adenylyl cyclase. J. Neurochem. 1994, 63:456.
52. Ullmer C., Schmuck K., Kalkman H.O., Lubbert H. Expression of serotonin receptor mRNAs in blood vessels. FEBS Lett. 1995, 370:215.
53. Uyanik A., Unal D., Uyanik M.H., Halici Z., Odabasoglu F., Altunkaynak Z.B., Cadirci E., Keles M., Gundogdu C., Suleyman H., Bayir Y., Albayrak M., Unal B. The effects of polymicrobial sepsis with diabetes mellitus on kidney tissues in ovariectomized rats. Ren. Fail. 2010, 32:592.
54. van den Berg R., Haenen G.R., van den Berg H., Bast A. Transcription factor NF-kappaB as a potential biomarker for oxidative stress. Br. J. Nutr. 2001, 86(Suppl. 1):S121.
55. Vincent J.L. Acute kidney injury, acute lung injury and septic shock: how does mortality compare?. Contrib. Nephrol. 2011, 174:71.
56. Wang P., Ba Z.F., Chaudry I.H. Mechanism of hepatocellular dysfunction during early sepsis. Key role of increased gene expression and release of proinflammatory cytokines tumor necrosis factor and interleukin-6. Arch. Surg. 1997, 132:364.
57. Wichterman K.A., Baue A.E., Chaudry I.H. Sepsis and septic shock--a review of laboratory models and a proposal. J Surg Res. 1980, 29:189-201.
58. Wood L.G., Gibson P.G., Garg M.L. Biomarkers of lipid peroxidation, airway inflammation and asthma. Eur. Respir. J. 2003, 21:177.
59. Yang C.M., Yo Y.L., Hsieh J.T., Ong R. 5-Hydroxytryptamine receptor-mediated phosphoinositide hydrolysis in canine cultured tracheal smooth muscle cells. Br. J. Pharmacol. 1994, 111:777.
60. Yang G.B., Qiu C.L., Zhao H., Liu Q., Shao Y. Expression of mRNA for multiple serotonin (5-HT) receptor types/subtypes by the peripheral blood mononuclear cells of rhesus macaques. J. Neuroimmunol. 2006, 178:24.